vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-1032Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИORIGINAL ARTICLESЧАСТОТА ИНФИЦИРОВАННОСТИ ВИРУСАМИ ПАПИЛЛОМЫ ЧЕЛОВЕКА ВЕРХНИХ ДЫХАТЕЛЬНЫХ ПУТЕЙ У ДЕТЕЙTHE RATE OF CONTAMINATION OF UPPER AIRWAYS WITH HUMAN PAPILLOMA VIRUSES IN CHILDRENСолдатскийЮ.Л.SoldatskiyYu.L.ОнуфриеваЕ.К.OnufrievaE.K.СтрыгинаЮ.В.StryginaYu.V.ПогосоваИ.Е.PogosovaI.E.ДюдяА.В.DyudyaA.V.Московская медицинская академия им. И.М. СеченоваРоссияI.M. Sechenov Moscow Medical AcademyRussian FederationДетская городская клиническая больница св. Владимира, МоскваРоссияSt. Vladimir Children's City Clinical Hospital, MoscowRussian FederationИнститут генных технологий, МоскваРоссияInstitute of Gene Technologies, MoscowRussian Federation20091809201581Вопросы современной педиатрии2024Copyright © Солдатский Ю., Онуфриева Е., Стрыгина Ю., Погосова И., Дюдя А., 20092009Солдатский Ю., Онуфриева Е., Стрыгина Ю., Погосова И., Дюдя А.Soldatskiy Y., Onufrieva E., Strygina Y., Pogosova I., Dyudya A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/1032ReferencesPfister H., Fuchs P.G. Anatomy, taxonomy and evolution of papillomaviruses. Intervirology. 1994; 37 (3–4): 143–149.Pfister H., Fuchs P.G. Anatomy, taxonomy and evolution of papillomaviruses. Intervirology. 1994; 37 (3–4): 143–149.Wiatrak B.J., Wiatrak D.W., Broker T.R. et al. Recurrent respiratory papillomatosis: a longitudional study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in large pediatric population. Laryngoscope. 2004; 114 (11): 23.Wiatrak B.J., Wiatrak D.W., Broker T.R. et al. Recurrent respiratory papillomatosis: a longitudional study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in large pediatric population. Laryngoscope. 2004; 114 (11): 23.von Krogh G. Management of anogenital warts (condylomata acuminata). Eur. J. Dermatol. 2001; 11 (6): 598–604.von Krogh G. Management of anogenital warts (condylomata acuminata). Eur. J. Dermatol. 2001; 11 (6): 598–604.Muсoz N., Bosch F.X., de Sanjose S. et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003; 348 (6): 518–527.Muсoz N., Bosch F.X., de Sanjose S. et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003; 348 (6): 518–527.Kreimer A.R., Clifford G.M., Boyle P. et al. Human papillomavirus types in head and neck squamous cell carcinomas word wide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005; 14 (2): 467–475.Kreimer A.R., Clifford G.M., Boyle P. et al. Human papillomavirus types in head and neck squamous cell carcinomas word wide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005; 14 (2): 467–475.D’Souza G., Kreimer A.R., Viscidi R. et al. Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 2007; 356 (19): 1944–1956.D’Souza G., Kreimer A.R., Viscidi R. et al. Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 2007; 356 (19): 1944–1956.Cutts F.T., Franceschi S., Goldie S. et al. Human papillomavirus and HPV vaccines: a review. Bulletin Word Health Organization. 2007; 85 (9): 719–726.Cutts F.T., Franceschi S., Goldie S. et al. Human papillomavirus and HPV vaccines: a review. Bulletin Word Health Organization. 2007; 85 (9): 719–726.Gissmann L., Diehl V., Schultz–Coulon H.J. et al. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J. Virol. 1982; 44 (1): 393–400.Gissmann L., Diehl V., Schultz–Coulon H.J. et al. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J. Virol. 1982; 44 (1): 393–400.Mounts P., Shah K.V., Kashima H. Viral etiology of juvenile and adult onset squamous papilloma of the larynx. Proc. Natl. Acad. Sci. USA. 1982; 79 (17): 5425–5429.Mounts P., Shah K.V., Kashima H. Viral etiology of juvenile and adult onset squamous papilloma of the larynx. Proc. Natl. Acad. Sci. USA. 1982; 79 (17): 5425–5429.Steinbrook R. The potential of human papillomavirus vaccines. N. Engl. J. Med. 2006; 354 (11): 1109–1112.Steinbrook R. The potential of human papillomavirus vaccines. N. Engl. J. Med. 2006; 354 (11): 1109–1112.Syrjanen S., Puranene M. Human papillomavirus infections in children: the potential role of maternal transmission. Crit. Rev. Oral. Biol. Med. 2000; 11 (2): 259–274.Syrjanen S., Puranene M. Human papillomavirus infections in children: the potential role of maternal transmission. Crit. Rev. Oral. Biol. Med. 2000; 11 (2): 259–274.Sisk J., Schweinfurth J.M., Wang X.T.et al. Presence of human papillomavirus DNA in tonsillectomy specimens. Laryngoscope. 2006; 116 (8): 1372–1374.Sisk J., Schweinfurth J.M., Wang X.T.et al. Presence of human papillomavirus DNA in tonsillectomy specimens. Laryngoscope. 2006; 116 (8): 1372–1374.Chen R., Sehr P., Waterboer T. et al. Presence of DNA human papillomavirus 16 but no other types in tumor free tonsillar tissue. J. Clin. Microbiol. 2005; 43 (3): 1408–1410.Chen R., Sehr P., Waterboer T. et al. Presence of DNA human papillomavirus 16 but no other types in tumor free tonsillar tissue. J. Clin. Microbiol. 2005; 43 (3): 1408–1410.Mammas I.N., Sourvinos G., Michael C. et al. Human papilloma virus in hyperplastic tonsillar and adenoid tissues in children. Pediatr. Infect. Dis. J. 2006; 25 (12): 1158–1162.Mammas I.N., Sourvinos G., Michael C. et al. Human papilloma virus in hyperplastic tonsillar and adenoid tissues in children. Pediatr. Infect. Dis. J. 2006; 25 (12): 1158–1162.Ribeiro K.M.X., Alvez J.M., Pignatari S.S.N. et al. Detection of human papilloma virus in the tonsils of children undergoing tonsillectomy. BJID. 2006; 10 (3): 165–168.Ribeiro K.M.X., Alvez J.M., Pignatari S.S.N. et al. Detection of human papilloma virus in the tonsils of children undergoing tonsillectomy. BJID. 2006; 10 (3): 165–168.Velyvyte D., Laiskonis A., Uloza V. et al. Prevalence of human papillomavirus infection among patients with laryngeal papillomatosis and the influence of some rick factors on the persistence of papillomaviruses in the upper respiratory tract. Medicina. 2002; 38 (5): 83–88.Velyvyte D., Laiskonis A., Uloza V. et al. Prevalence of human papillomavirus infection among patients with laryngeal papillomatosis and the influence of some rick factors on the persistence of papillomaviruses in the upper respiratory tract. Medicina. 2002; 38 (5): 83–88.Szydlowski J., Durzynski L., Myga M. et al. Human papillomavirus DNA presence of the upper respiratory tract mucosa of healthy children. Otolaryngol. Pol. 2004; 58 (1): 211–215.Szydlowski J., Durzynski L., Myga M. et al. Human papillomavirus DNA presence of the upper respiratory tract mucosa of healthy children. Otolaryngol. Pol. 2004; 58 (1): 211–215.Boom R., Sol C.J., Salimans M.M. et al. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 1990; 28 (3): 495–503.Boom R., Sol C.J., Salimans M.M. et al. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 1990; 28 (3): 495–503.Овчинников Ю.М., Киселев В.И., Солдатский Ю.Л. и др. Распространенность типов вируса папилломы человека и их влияние на течение заболевания у детей, страдающих рецидивирующим респираторным папилломатозом. Вестник оторинолар. 2004; 3: 29–33.Овчинников Ю.М., Киселев В.И., Солдатский Ю.Л. и др. Распространенность типов вируса папилломы человека и их влияние на течение заболевания у детей, страдающих рецидивирующим респираторным папилломатозом. Вестник оторинолар. 2004; 3: 29–33.Солдатский Ю.Л., Онуфриева Е.К., Щепин Н.В. и др. Исходы ювенильного респираторного папилломатоза. Российская оториноларингология. 2004; 4 (11): 70–73.Солдатский Ю.Л., Онуфриева Е.К., Щепин Н.В. и др. Исходы ювенильного респираторного папилломатоза. Российская оториноларингология. 2004; 4 (11): 70–73.FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high grade cervical lesions. N. Engl. J. Med. 2007; 356 (19): 1915-1927.FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high grade cervical lesions. N. Engl. J. Med. 2007; 356 (19): 1915-1927.Garland S.M., Hernandez Avila M., Wheeler C.M. et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N. Engl. J. Med. 2007; 356 (19): 1928– 1943.Garland S.M., Hernandez Avila M., Wheeler C.M. et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N. Engl. J. Med. 2007; 356 (19): 1928– 1943.
The authors declare that there are no conflicts of interest present.